vs
Side-by-side financial comparison of Hippo Holdings Inc. (HIPO) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
Hippo Holdings Inc. is the larger business by last-quarter revenue ($120.4M vs $76.2M, roughly 1.6× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 5.0%, a 2.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 18.2%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $9.1M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 18.9%).
Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
HIPO vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.4M | $76.2M |
| Net Profit | $6.0M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 5.6% | 11.0% |
| Net Margin | 5.0% | 7.4% |
| Revenue YoY | 18.2% | 25.5% |
| Net Profit YoY | -86.4% | 30.7% |
| EPS (diluted) | $0.31 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.4M | $76.2M | ||
| Q3 25 | $120.6M | $71.9M | ||
| Q2 25 | $117.3M | $63.1M | ||
| Q1 25 | $110.3M | $59.1M | ||
| Q4 24 | $101.9M | $60.7M | ||
| Q3 24 | $95.5M | $58.0M | ||
| Q2 24 | $89.6M | $55.0M | ||
| Q1 24 | $85.1M | $50.6M |
| Q4 25 | $6.0M | $5.6M | ||
| Q3 25 | $98.1M | $3.5M | ||
| Q2 25 | $1.3M | $3.2M | ||
| Q1 25 | $-47.7M | $2.6M | ||
| Q4 24 | $44.2M | $4.3M | ||
| Q3 24 | $-8.5M | $3.9M | ||
| Q2 24 | $-40.5M | $1.5M | ||
| Q1 24 | $-35.7M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 5.6% | 11.0% | ||
| Q3 25 | 81.3% | 7.8% | ||
| Q2 25 | 3.4% | 8.1% | ||
| Q1 25 | -41.3% | 6.5% | ||
| Q4 24 | 46.3% | 10.6% | ||
| Q3 24 | -5.4% | 9.7% | ||
| Q2 24 | -40.7% | 6.6% | ||
| Q1 24 | -38.7% | 4.4% |
| Q4 25 | 5.0% | 7.4% | ||
| Q3 25 | 81.3% | 4.9% | ||
| Q2 25 | 1.1% | 5.0% | ||
| Q1 25 | -43.2% | 4.4% | ||
| Q4 24 | 43.4% | 7.1% | ||
| Q3 24 | -8.9% | 6.7% | ||
| Q2 24 | -45.2% | 2.7% | ||
| Q1 24 | -42.0% | 3.2% |
| Q4 25 | $0.31 | $0.14 | ||
| Q3 25 | $3.77 | $0.09 | ||
| Q2 25 | $0.05 | $0.08 | ||
| Q1 25 | $-1.91 | $0.06 | ||
| Q4 24 | $1.81 | $0.10 | ||
| Q3 24 | $-0.34 | $0.10 | ||
| Q2 24 | $-1.64 | $0.04 | ||
| Q1 24 | $-1.47 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $218.3M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $436.1M | $141.5M |
| Total Assets | $1.9B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.3M | $13.5M | ||
| Q3 25 | $247.7M | $11.1M | ||
| Q2 25 | $198.9M | $20.0M | ||
| Q1 25 | $140.9M | $10.2M | ||
| Q4 24 | $197.6M | $17.5M | ||
| Q3 24 | $191.2M | $11.3M | ||
| Q2 24 | $175.9M | $8.8M | ||
| Q1 24 | $223.4M | $7.3M |
| Q4 25 | $436.1M | $141.5M | ||
| Q3 25 | $421.5M | $133.6M | ||
| Q2 25 | $332.5M | $139.7M | ||
| Q1 25 | $322.8M | $134.8M | ||
| Q4 24 | $362.1M | $131.4M | ||
| Q3 24 | $326.4M | $125.0M | ||
| Q2 24 | $322.6M | $119.4M | ||
| Q1 24 | $351.2M | $116.3M |
| Q4 25 | $1.9B | $199.2M | ||
| Q3 25 | $1.9B | $202.4M | ||
| Q2 25 | $1.7B | $184.6M | ||
| Q1 25 | $1.5B | $178.1M | ||
| Q4 24 | $1.5B | $177.1M | ||
| Q3 24 | $1.5B | $169.5M | ||
| Q2 24 | $1.5B | $163.9M | ||
| Q1 24 | $1.5B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.2M | $18.4M |
| Free Cash FlowOCF − Capex | $9.1M | $9.7M |
| FCF MarginFCF / Revenue | 7.6% | 12.7% |
| Capex IntensityCapex / Revenue | 0.1% | 11.5% |
| Cash ConversionOCF / Net Profit | 1.53× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $14.8M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.2M | $18.4M | ||
| Q3 25 | $16.9M | $18.4M | ||
| Q2 25 | $24.7M | $12.3M | ||
| Q1 25 | $-35.6M | $2.9M | ||
| Q4 24 | $47.5M | $15.0M | ||
| Q3 24 | $46.8M | $12.7M | ||
| Q2 24 | $-10.6M | $10.2M | ||
| Q1 24 | $17.7M | $1.2M |
| Q4 25 | $9.1M | $9.7M | ||
| Q3 25 | $16.8M | $10.7M | ||
| Q2 25 | $24.6M | $4.1M | ||
| Q1 25 | $-35.7M | $-12.6M | ||
| Q4 24 | $47.2M | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $-10.7M | $1.2M | ||
| Q1 24 | $17.6M | $-4.8M |
| Q4 25 | 7.6% | 12.7% | ||
| Q3 25 | 13.9% | 14.9% | ||
| Q2 25 | 21.0% | 6.5% | ||
| Q1 25 | -32.4% | -21.4% | ||
| Q4 24 | 46.3% | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | -11.9% | 2.3% | ||
| Q1 24 | 20.7% | -9.5% |
| Q4 25 | 0.1% | 11.5% | ||
| Q3 25 | 0.1% | 10.6% | ||
| Q2 25 | 0.1% | 12.9% | ||
| Q1 25 | 0.1% | 26.2% | ||
| Q4 24 | 0.3% | 19.5% | ||
| Q3 24 | 0.0% | 19.0% | ||
| Q2 24 | 0.1% | 16.3% | ||
| Q1 24 | 0.1% | 11.9% |
| Q4 25 | 1.53× | 3.27× | ||
| Q3 25 | 0.17× | 5.23× | ||
| Q2 25 | 19.00× | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | 1.07× | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
